Peptide-based materials for cancer immunotherapy

Lu Zhang, Yanyu Huang, Aaron Raymond Lindstrom, Tzu Yin Lin, Kit S. Lam, Yuanpei Li

Research output: Contribution to journalReview article

Abstract

Peptide-based materials hold great promise as immunotherapeutic agents for the treatment of many malignant cancers. Extensive studies have focused on the development of peptide-based cancer vaccines and delivery systems by mimicking the functional domains of proteins with highly specific immuno-regulatory functions or tumor cells fate controls. However, a systemic understanding of the interactions between the different peptides and immune systems remains unknown. This review describes the role of peptides in regulating the functions of the innate and adaptive immune systems and provides a comprehensive focus on the design, categories, and applications of peptide-based cancer vaccines. By elucidating the impacts of peptide length and formulations on their immunogenicity, peptide-based immunomodulating agents can be better utilized and dramatic breakthroughs may also be realized. Moreover, some critical challenges for translating peptides into large-scale synthesis, safe delivery, and efficient cancer immunotherapy are posed to improve the next-generation peptide-based immunotherapy.

Original languageEnglish (US)
Pages (from-to)7807-7825
Number of pages19
JournalTheranostics
Volume9
Issue number25
DOIs
StatePublished - Jan 1 2019

Fingerprint

Immunotherapy
Peptides
Neoplasms
Cancer Vaccines
Immune System

Keywords

  • Cancer immunotherapy
  • Peptide-based materials

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Zhang, L., Huang, Y., Lindstrom, A. R., Lin, T. Y., Lam, K. S., & Li, Y. (2019). Peptide-based materials for cancer immunotherapy. Theranostics, 9(25), 7807-7825. https://doi.org/10.7150/thno.37194

Peptide-based materials for cancer immunotherapy. / Zhang, Lu; Huang, Yanyu; Lindstrom, Aaron Raymond; Lin, Tzu Yin; Lam, Kit S.; Li, Yuanpei.

In: Theranostics, Vol. 9, No. 25, 01.01.2019, p. 7807-7825.

Research output: Contribution to journalReview article

Zhang, L, Huang, Y, Lindstrom, AR, Lin, TY, Lam, KS & Li, Y 2019, 'Peptide-based materials for cancer immunotherapy', Theranostics, vol. 9, no. 25, pp. 7807-7825. https://doi.org/10.7150/thno.37194
Zhang, Lu ; Huang, Yanyu ; Lindstrom, Aaron Raymond ; Lin, Tzu Yin ; Lam, Kit S. ; Li, Yuanpei. / Peptide-based materials for cancer immunotherapy. In: Theranostics. 2019 ; Vol. 9, No. 25. pp. 7807-7825.
@article{ab59b0e17c4a4844ada06e24a6ad424a,
title = "Peptide-based materials for cancer immunotherapy",
abstract = "Peptide-based materials hold great promise as immunotherapeutic agents for the treatment of many malignant cancers. Extensive studies have focused on the development of peptide-based cancer vaccines and delivery systems by mimicking the functional domains of proteins with highly specific immuno-regulatory functions or tumor cells fate controls. However, a systemic understanding of the interactions between the different peptides and immune systems remains unknown. This review describes the role of peptides in regulating the functions of the innate and adaptive immune systems and provides a comprehensive focus on the design, categories, and applications of peptide-based cancer vaccines. By elucidating the impacts of peptide length and formulations on their immunogenicity, peptide-based immunomodulating agents can be better utilized and dramatic breakthroughs may also be realized. Moreover, some critical challenges for translating peptides into large-scale synthesis, safe delivery, and efficient cancer immunotherapy are posed to improve the next-generation peptide-based immunotherapy.",
keywords = "Cancer immunotherapy, Peptide-based materials",
author = "Lu Zhang and Yanyu Huang and Lindstrom, {Aaron Raymond} and Lin, {Tzu Yin} and Lam, {Kit S.} and Yuanpei Li",
year = "2019",
month = "1",
day = "1",
doi = "10.7150/thno.37194",
language = "English (US)",
volume = "9",
pages = "7807--7825",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "25",

}

TY - JOUR

T1 - Peptide-based materials for cancer immunotherapy

AU - Zhang, Lu

AU - Huang, Yanyu

AU - Lindstrom, Aaron Raymond

AU - Lin, Tzu Yin

AU - Lam, Kit S.

AU - Li, Yuanpei

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Peptide-based materials hold great promise as immunotherapeutic agents for the treatment of many malignant cancers. Extensive studies have focused on the development of peptide-based cancer vaccines and delivery systems by mimicking the functional domains of proteins with highly specific immuno-regulatory functions or tumor cells fate controls. However, a systemic understanding of the interactions between the different peptides and immune systems remains unknown. This review describes the role of peptides in regulating the functions of the innate and adaptive immune systems and provides a comprehensive focus on the design, categories, and applications of peptide-based cancer vaccines. By elucidating the impacts of peptide length and formulations on their immunogenicity, peptide-based immunomodulating agents can be better utilized and dramatic breakthroughs may also be realized. Moreover, some critical challenges for translating peptides into large-scale synthesis, safe delivery, and efficient cancer immunotherapy are posed to improve the next-generation peptide-based immunotherapy.

AB - Peptide-based materials hold great promise as immunotherapeutic agents for the treatment of many malignant cancers. Extensive studies have focused on the development of peptide-based cancer vaccines and delivery systems by mimicking the functional domains of proteins with highly specific immuno-regulatory functions or tumor cells fate controls. However, a systemic understanding of the interactions between the different peptides and immune systems remains unknown. This review describes the role of peptides in regulating the functions of the innate and adaptive immune systems and provides a comprehensive focus on the design, categories, and applications of peptide-based cancer vaccines. By elucidating the impacts of peptide length and formulations on their immunogenicity, peptide-based immunomodulating agents can be better utilized and dramatic breakthroughs may also be realized. Moreover, some critical challenges for translating peptides into large-scale synthesis, safe delivery, and efficient cancer immunotherapy are posed to improve the next-generation peptide-based immunotherapy.

KW - Cancer immunotherapy

KW - Peptide-based materials

UR - http://www.scopus.com/inward/record.url?scp=85074323970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074323970&partnerID=8YFLogxK

U2 - 10.7150/thno.37194

DO - 10.7150/thno.37194

M3 - Review article

C2 - 31695802

AN - SCOPUS:85074323970

VL - 9

SP - 7807

EP - 7825

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 25

ER -